Role of Helicobacter pylori in gastric carcinogenesis:: The origin of gastric cancers and heterotopic proliferative glands in Mongolian gerbils

被引:45
作者
Tatematsu, M [1 ]
Tsukamoto, T [1 ]
Mizoshita, T [1 ]
机构
[1] Aichi Canc Ctr, Res Inst, Div Oncol Pathol, Chikusa Ku, Nagoya, Aichi 4648681, Japan
关键词
D O I
10.1111/j.1523-5378.2005.00305.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Helicobacter pylori infection is well accepted to be a very important factor for the development of gastric carcinogenesis in the human stomach. In Mongolian gerbils treated with chemical carcinogens, H. pylori infection enhances glandular stomach carcinogenesis, and eradication of infection and results in curtailment of enhancing effects, particularly at early stages of associated inflammation. A high-salt diet exacerbates the effects of H. pylori infection on gastric carcinogenesis, and these two factors act synergistically to promote the development of gastric cancers in this animal model. However, the bacterium exerts the greater effects. Early acquisition significantly increases gastric chemical carcinogenesis in Mongolian gerbils, as compared to later infection. While heterotopic proliferative glands, hyperplastic and dilated glands localized beneath the muscularis mucosae, frequently develop with H. pylori infection alone in this animal model, they obviously regress on eradication, suggesting a relation to severe gastritis, rather than a malignant character. Furthermore, endocrine cells, positive for chromogranin A, are observed in the heterotopic proliferative glands, in contrast to cancerous lesions which lack endocrine elements. In conclusion, H. pylori is not an initiator, but rather a strong promoter of gastric carcinogenesis, whose eradication, together with reduction in salt intake, might effectively prevent gastric cancer development.
引用
收藏
页码:97 / 106
页数:10
相关论文
共 103 条
[1]
Expression of intestine-specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas [J].
Almeida, R ;
Silva, E ;
Santos-Silva, F ;
Silberg, DG ;
Wang, JF ;
De Bolós, C ;
David, L .
JOURNAL OF PATHOLOGY, 2003, 199 (01) :36-40
[2]
Asaka M, 1996, Helicobacter, V1, P52, DOI 10.1111/j.1523-5378.1996.tb00008.x
[3]
RELATIONSHIP OF HELICOBACTER-PYLORI TO SERUM PEPSINOGENS IN AN ASYMPTOMATIC JAPANESE POPULATION [J].
ASAKA, M ;
KIMURA, T ;
KUDO, M ;
TAKEDA, H ;
MITANI, S ;
MIYAZAKI, T ;
MIKI, K ;
GRAHAM, DY .
GASTROENTEROLOGY, 1992, 102 (03) :760-766
[4]
Time-dependent expression of intestinal phenotype in signet ring cell carcinomas of the human stomach [J].
Bamba, M ;
Sugihara, H ;
Kushima, R ;
Okada, K ;
Tsukashita, S ;
Horinouchi, M ;
Hattori, T .
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 2001, 438 (01) :49-56
[5]
BJAW JRM, 1984, LANCET, P1311
[6]
Eradication of Helicobacter pylori induces apoptosis and inhibits proliferation glands in infected Mongolian gerbils [J].
Cao, XY ;
Tsukamoto, T ;
Nozaki, K ;
Shimizu, N ;
Mizoshita, T ;
Kumagai, T ;
Kaminishi, M ;
Tatematsu, M .
CANCER SCIENCE, 2004, 95 (11) :872-877
[7]
Earlier Helicobacter pylori infection increases the risk for the N-methyl-N-nitrosourea-induced stomach carcinogenesis in Mongolian gerbils [J].
Cao, XY ;
Tsukamoto, T ;
Nozaki, K ;
Tanaka, H ;
Shimizu, N ;
Kaminishi, M ;
Kumagai, T ;
Tatematsu, M .
JAPANESE JOURNAL OF CANCER RESEARCH, 2002, 93 (12) :1293-1298
[8]
Chemoprevention of gastric dysplasia:: Randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy [J].
Correa, P ;
Fontham, ETH ;
Bravo, JC ;
Bravo, LE ;
Ruiz, B ;
Zarama, G ;
Realpe, JL ;
Malcom, GT ;
Li, D ;
Johnson, WD ;
Mera, R .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (23) :1881-1888
[9]
CORREA P, 1995, AM J SURG PATHOL, V19, pS37
[10]
CORREA P, 1988, CANCER RES, V48, P3554